Healthy Subjects Clinical Trial
Official title:
Study of Normative Metrics of High-resolution Anorectal Manometry With the Use of Water-perfused Catheter in a Russian Population Without Signs of Functional and Organic Anorectal Disorders
NCT number | NCT03897296 |
Other study ID # | HRAM-HV |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | April 15, 2019 |
Est. completion date | April 15, 2024 |
High resolution anorectal manometry (HRAM) normative values are still need to be studied in different populations and with the use of different (solid-state and water-perfused) systems. No studies on HRAM normative values in a Russian population without signs of functional and organic anorectal pathology has been carried out yet.
Status | Recruiting |
Enrollment | 120 |
Est. completion date | April 15, 2024 |
Est. primary completion date | April 15, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Willingness to participate in this clinical trial, confirmed by signed informed consent form. - Patients of both sexes, aged 18 to 65 years inclusive. - Permanent residence in the Russian Federation (capable citizens of Russia on the basis of a passport of a citizen of the Russian Federation). - Absence of rectal diseases, confirmed by the results of clinical and instrumental examinations - Ability to follow the instructions when high-resolution anorectal manometry procedure is performed. Exclusion Criteria: - Known diseases of the rectum on the basis of clinical and / or instrumental examination, including presence of complaints to difficulties with defecations that require manual aids or use of laxatives; - Surgical interventions on pelvic organs in history; - History of organ transplantation except for corneal transplantation and eye lens replacement surgery; - Oncology of any localization, with the exception of skin cancer in situ; - Severe concomitant pathology of any organs and systems, which, in the opinion of the researcher, makes it impossible to carry out the procedure of high-resolution anorectal manometry or if the procedure may cause the risk of worsen the patient's condition; - Absence of anamnestic, clinical and laboratory signs of alcohol abuse (abuse will be considered in case of the use of more than 30 g of pure alcohol per day by males and the use of more than 20 g of pure alcohol per day by females; - Use of illegal drugs, including history; - Use of concomitant medications that can affect the motor function of the colon (including, but not limited to: calcium channel blockers, metoclopramide, m-cholinolytics, domperidone, nitrates, tricyclic antidepressants, opiates, beta-blockers, beta-adrenomimetics, alcohol). The duration of the period of non-use of these drugs should provide sufficient time for the complete cessation of their pharmacological action, but not less than two half-life periods. - Pregnancy and breast-feeding; - Technical impossibility to insert the catheter due to the previously known or current poor tolerability of high-resolution anorectal manometry procedure or due to the presence of anatomical features that make it impossible to insert the catheter. Criteria of non-inclusion of the data to the analysis: - Patients may choose to stop their participation in the study by withdrawal of their previously signed consent, that leads to the exclusion of their data from the analysis. The researcher should be guided by the following criteria, however, he may at any time terminate the patient's participation in the study on the basis of his own clinical judgment. Cancellation of participation in the study can be carried out on the basis of the following events: 1. Lack of the possibility to insert water-perfused catheter during high-resolution anorectal manometry procedure due to anatomical features or psychological state of the patient. 2. Incomplete high-resolution anorectal manometry procedure. 3. Presence of adverse event(s) during high-resolution anorectal manometry procedure, causing the further procedure impossible. 4. Obtaining incomplete recording of high-resolution anorectal manometry parameters for any reason. 5. Identification of the conditions described in the section "exclusion criteria" during examination of the patient. |
Country | Name | City | State |
---|---|---|---|
Russian Federation | Gastroenterology and Hepatology, FRC Nutrition and Biotechnology | Moscow | |
Russian Federation | State Scientific Center of Coloproctology | Moscow |
Lead Sponsor | Collaborator |
---|---|
Russian Academy of Medical Sciences | Federal Research Centre of Nutrition and Biotechnology, State Scientific Centre of Coloproctology, Russian Federation |
Russian Federation,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Resting anorectal pressure obtained with the use of water-perfused catheter for high-resolution anorectal manometry | Anorectal pressure at rest, mm Hg | 1 minute | |
Primary | Maximal squeeze pressure obtained with the use of water-perfused catheter for high-resolution anorectal manometry | Maximal pressure when a squeeze test is performed, mm Hg | 5 seconds | |
Primary | Maximal pressure of endurance squeeze test performed with the use of water-perfused catheter for high-resolution anorectal manometry | mean pressure during test, mm Hg | 30 seconds | |
Primary | Push test pressure obtained with the use of water-perfused catheter for high-resolution anorectal manometry | mean pressure during push test, mm Hg | 5 seconds | |
Primary | Cough test | Cough test pressure, maximal | 5 seconds | |
Primary | Pressure of the first sensation obtained with the use of water-perfused catheter for high-resolution anorectal manometry | Pressure of the first sensation by the test of reservoir function of the rectum, mm Hg | 1 minute | |
Primary | Pressure of the urge to defecate obtained with the use of water-perfused catheter for high-resolution anorectal manometry | Pressure of the urge to defecate by the test of reservoir function of the rectum, mm Hg | 1 minute | |
Primary | Maximal tolerate volume pressure obtained with the use of water-perfused catheter for high-resolution anorectal manometry | Maximal tolerate volume pressure by the test of reservoir function of the rectum, ml | 1 minute | |
Primary | First pain sensation pressure obtained with the use of water-perfused catheter for high-resolution anorectal manometry | Appearance of pain sensation by the test of reservoir function of the rectum, mm Hg | 1 minute |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05483998 -
A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants
|
Phase 1 | |
Recruiting |
NCT02235012 -
Cognitive Biases Under Ketamine
|
N/A | |
Recruiting |
NCT02417714 -
Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
|
||
Completed |
NCT05088343 -
Effect of Hetrombopag on the Pharmacokinetics of Rosuvastatin in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04418973 -
Analysis of Breath Volatile Organic Compounds After Dyspnea Induced in the Healthy Subject.
|
N/A | |
Not yet recruiting |
NCT06248801 -
Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets
|
Phase 1 | |
Terminated |
NCT04068259 -
Single Ascending Dose Study of PBI-4547 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT03279302 -
Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects
|
Phase 1 | |
Not yet recruiting |
NCT06233162 -
Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets
|
Phase 1 | |
Recruiting |
NCT04159844 -
Evaluation of the Stiffness and Pressure Applied on the Lower Leg by a New Compression Bandage on Healthy Subjects
|
N/A | |
Completed |
NCT06137911 -
Evaluation of Safety, Tolerability & Pharmacokinetics of JYP0061 in Healthy Adults.
|
Phase 1 | |
Completed |
NCT04849286 -
Measurement of HTL0016878 in Cerebrospinal Fluid
|
Phase 1 | |
Not yet recruiting |
NCT06233227 -
Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule
|
Phase 1 | |
Completed |
NCT04096157 -
A Study to Assess Isavuconazole Following a Single Dose of Isavuconazonium Sulfate Intravenous Solution Via Nasogastric (NG) Tube Compared to a Single Dose of Oral Capsules Under Fasting Conditions in Healthy Participants
|
Phase 1 | |
Completed |
NCT01200368 -
Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants
|
Phase 3 | |
Recruiting |
NCT05805033 -
Peri-Implant Soft Tissue Integration in Humans: Influence of Material
|
N/A | |
Completed |
NCT04027803 -
Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Single Intravenous Doses of BCD-148 and Soliris®
|
Phase 1 | |
Recruiting |
NCT03467880 -
Multicenter Study of Impulse Oscillometry in Chinese
|
N/A | |
Completed |
NCT02903095 -
Single Ascending Dose Study of TD-1439 in Healthy Subjects
|
Phase 1 | |
Active, not recruiting |
NCT02341508 -
A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Lpathomab in Healthy Volunteers
|
Phase 1 |